MJP Associates Inc. ADV bought a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, Holdings Channel reports. The fund bought 16,086 shares of the company’s stock, valued at approximately $2,067,000.
Other institutional investors have also recently added to or reduced their stakes in the company. Danske Bank A S acquired a new position in Merck KGaA in the 2nd quarter valued at approximately $276,535,000. Great Lakes Advisors LLC acquired a new position in shares of Merck KGaA during the second quarter worth $183,444,000. Tocqueville Asset Management L.P. acquired a new position in shares of Merck KGaA during the second quarter worth $57,546,000. Edmond DE Rothschild Holding S.A. bought a new stake in shares of Merck KGaA in the second quarter worth $51,346,000. Finally, Vise Technologies Inc. bought a new stake in shares of Merck KGaA in the second quarter worth $27,990,000. 0.10% of the stock is owned by institutional investors.
Merck KGaA Stock Performance
OTCMKTS MKGAF opened at $162.12 on Friday. The company has a market capitalization of $20.95 billion, a price-to-earnings ratio of 24.75 and a beta of 0.96. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56. The stock has a fifty day simple moving average of $162.47 and a 200 day simple moving average of $148.35. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
